Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
79 hedge funds and large institutions have $720M invested in Amryt Pharma plc American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 18 closing their positions.
133% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 18
126% more capital invested
Capital invested by funds: $318M → $720M (+$402M)
57% more funds holding in top 10
Funds holding in top 10: 7 → 11 (+4)
39% more funds holding
Funds holding: 57 → 79 (+22)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $20K | Put options by funds: $85.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$35.3M |
| 2 |
Morgan Stanley
New York
|
+$34.2M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$28.3M |
| 4 |
TAL
TIG Advisors LLC
New York
|
+$23.6M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$22.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$26.3M |
| 2 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
-$16.6M |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$15.3M |
| 4 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$12.6M |
| 5 |
Man Group
London,
United Kingdom
|
-$9.56M |
AMYT Hedge Fund Activity: Q1 2023 in Review
79 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q1 2023, worth a combined $720M — up 126% from $318M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new AMYT positions and 18 closed out — a net gain of 24 holders — while 8 added to existing stakes and 10 trimmed.
The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $35.3M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $26.3M sold.
- 79 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q1 2023, up from 57 in Q4 2022.
- Funds reported $720M of Amryt Pharma plc American Depositary Shares stock for Q1 2023, up 126% quarter-over-quarter.
- 42 funds opened new Amryt Pharma plc American Depositary Shares positions in Q1 2023 and 18 closed out, a net change of +24 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q1 2023 was Pentwater Capital Management, an estimated $35.3M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q1 2023 was Rubric Capital Management (New York), an estimated $26.3M sold.
Based on aggregated 13F filings for Q1 2023.